相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Developing an Objective Marker to Optimize Patient Selection and Predict Survival Benefit in Early-Phase Cancer Trials
Chara Stavraka et al.
CANCER (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials
David J. Pinato et al.
PLOS ONE (2014)
Validation of the pre-treatment neutrophil lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
M. Pichler et al.
BRITISH JOURNAL OF CANCER (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
Haemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction of the TNM Staging System in Nasopharyngeal Carcinoma: Development and Validation in 3237 Patients from a Single Institution
H. Chang et al.
CLINICAL ONCOLOGY (2013)
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer
Graeme J. K. Guthrie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin
A. Ploquin et al.
BRITISH JOURNAL OF CANCER (2012)
Tumor-associated neutrophils: friend or foe?
Zvi G. Fridlender et al.
CARCINOGENESIS (2012)
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival, and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
Daniel Keizman et al.
EUROPEAN JOURNAL OF CANCER (2012)
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
Daniel Keizman et al.
ONCOLOGIST (2012)
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?
Nicole G. Chau et al.
BMC CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials
David Olmos et al.
CLINICAL CANCER RESEARCH (2011)
A new, simple and objective prognostic score for phase I cancer patients
L. M. Fussenich et al.
EUROPEAN JOURNAL OF CANCER (2011)
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
Xin An et al.
BIOMARKERS (2010)
High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
Steven C. H. Kao et al.
CLINICAL CANCER RESEARCH (2010)
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Craig P. Carden et al.
DRUG DISCOVERY TODAY (2010)
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics
Nicolas Penel et al.
INVESTIGATIONAL NEW DRUGS (2010)
Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
Yoji Kishi et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
HanByoul Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
Sanjiv S. Agarwala et al.
EUROPEAN JOURNAL OF CANCER (2009)
Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
Hendrik-Tobias Arkenau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
Khaled M. Sarraf et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
Takeharu Yamanaka et al.
ONCOLOGY (2007)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
H Schmidt et al.
BRITISH JOURNAL OF CANCER (2005)
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
TG Roberts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
分享论文
